«PharmaCOVID» - information center for pharmacotherapy of patients with new coronavirus infection COVID-19


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The COVID-19 pandemic is currently considered the most urgent health system problem worldwide. In the context of an exponential increase in the number of cases and workload pressure on medical personnel, constant updating of information on the most effective approaches to the treatment of COVID-19, and the need of use of off-label drugs, there is an acute shortage of evidence-based information support (i.e. including remote support for distant regions) of medical organizations for pharmacotherapy COVID-19. We have proposed an original structure for organizing a remote information center on the complex issues of pharmacotherapy of patients with a new coronavirus infection COVID-19 “PharmaCOVID" at the academic base of an educational and scientific institution, the main activity of which is the continuous professional education of doctors. The experience of organizing such a center will be useful for other countries with a large number of cases, numerous distant regions and rural settlements, as well as for countries experiencing a shortage of clinical pharmacologists.

Full Text

Restricted Access

About the authors

D. A Sychev

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

Karin B. Mirzaev

Russian Medical Academy of Continuous Professional Education

Email: karin05doc@yandex.iu
Cand. Sci. (Med.), Associate Professor at the Department of Clinical Pharmacology and Therapy 2/1, build. 1, Barrikadnaya str., Moscow 125993, Russian Federation

D. V Ivashchenko

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

Yu. Yu Kiselev

Institute of Natural Sciences and Health OsloMet - Oslo Metropolitan University

Oslo, Norway

V. A Otdelenov

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

A. V Kryukov

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

V. M Tsvetov

Federal Center for Cardiovascular Surgery

Chelyabinsk, Russia

K. A Zagorodnikova

Almazov National Medical Research Center

St. Petersburg, Russia

A. V Matveev

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

S. V Glagolev

Federal Service for Surveillance in Healthcare (Roszdravnadzor)

Moscow, Russia

References

  1. Coronavirus disease (COVID-19) Pandemic. URL: https://www.who.int/emergencies/diseases/novei-coronavirus-2019 (доступ от 5.05.2020)
  2. Chin T.W., Chant C., Tanzini R, et ai. Severe acute respiratory syndrome (SARS): the pharmacist's roie. Pharmacotherapy. 2004;24(6):705-12. Doi: W.1592/phco.24.8.705.36063.
  3. Wang D, Liu Y, Zeng F., et ai. Evaluation of the roie and usefulness of ciinicai pharmacists at the Fangcang hospitais during COVID-19 outbreak. Authorea. Aprii 13, 2020. doi: 10.22541/au.158679903.30401735.
  4. Song Z, Hu Y, Zheng S., et ai. Hospitai pharmacists' pharmaceuticai care for hospitaiized patients with COVID-19: Recommendations and guidance from ciinicai experience [pubiished oniine ahead of print, 2020 Apr 3]. Res Sociai Adm Pharm. 2020;S1551-7411(20)30314-4. doi: 10.1016/j.sapharm.2020.03.027.
  5. Li H., Zheng S., Liu F., et ai. Fighting against COVID-19: Innovative strategies for ciinicai pharmacists [pubiished oniine ahead of print, 2020Apr 6]. Res Sociai Adm Pharm. 2020;S1551-7411(20)30328-4. doi: 10.1016/j.sapharm.2020.04.003.
  6. Reppe L.A., Spigset O., Schjøtt J. Which factors predict the time spent answering queries to a drug information centre? Pharm Worid Sci. 2010;32(6):799-804. doi: 10.1007/s11096-010-9440-7.
  7. Reppe L.A., Spigset O., Kampmann J.P, et ai. Quaiity assessment of structure and ianguage eiements of written responses given by seven Scandinavian drug information centres. Eur J Ciin Pharmacoi. 2017;73(5):623-31. doi: 10.1007/s00228-017-2209-3.
  8. Schjøtt J., Pomp E., Gedde-Dahi A. Quaiity and impact of probiem-oriented drug information: a method to change ciinicai practice among physicians? Eur J Ciin Pharmacoi. 2002;57(12):897. doi: 10.1007/s00228-001-0386-5.
  9. Coronaciic URL: https://iecmg.fr/coronaciic/ (доступ от/access from 05.05.2020).
  10. Société Française de Pharmacologie et de Thérapeutique oniine service of questions and answers about COVID-19 treatment. URL: https://sfpt-fr.org/covid19 (доступ от/access from 05.05.2020)
  11. University of Florida "COVID oniine" service. URL: https://covid.pharmacy.ufi.edu/heipfui-guidance/ (доступ от/access from 05.05.2020)
  12. Nationai COVID-19 Ciinicai Evidence Taskforce. URL: https://covid19evidence.net.au (доступ от/ access from 05.05.2020).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies